全国范围分析2型糖尿病中逐渐下降的功能和糖尿病性黄斑
Jawad Muayad1, Hajar N Tukur2, Asad Loya3
1School of Medicine, Texas A&M University, Houston, Texas.
Ophthalmology science
|November 11, 2025
概括
功能下降增加了2型糖尿病患者糖尿病黄斑风险. 对于那些功能受损的人来说,积极的眼科查至关重要.
科学领域:
- 眼科医生 眼科 眼科
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病黄斑 (DME) 是导致2型糖尿病 (T2DM) 视力丧失的主要原因.
- 功能是糖尿病管理和并发症发展的关键因素.
- 不同程度的功能障碍对DME风险的具体影响需要进一步阐明.
研究的目的:
- 为了研究通过估计的膜过率 (eGFR) 测量功能与新诊断的2型糖尿病 (T2DM) 患者糖尿病黄斑胀 (DME) 的发生率之间的关联.
- 为了确定DME的风险是否随着功能下降而逐渐增加.
- 探索eGFR对DME风险的独立影响,即使没有显著的白色素尿.
主要方法:
- 使用TriNetX电子健康记录网络进行的回顾性队列研究.
- 患有T2DM的患者根据基线eGFR水平 (正常/高,轻度CKD,轻度至中度CKD,中度至重度CKD,重度CKD,ESRD) 被分为两类.
- 倾向性得分匹配用于平衡共变量,然后对T2DM诊断后3年内DME发病率进行分析.
主要成果:
- 与正常功能患者相比,DME风险在功能下降时显著逐渐增加.
- 对DME的危险比率从轻度CKD的1.05增加到ESRD的2.53.
- 亚组分析证实了较低的eGFR与较高的DME风险之间的关联,独立于albuminuria. 在ESRD患者中,移植与降低DME风险有关.
结论:
- 功能下降独立地与T2DM患者患糖尿病黄斑胀的风险逐渐增加有关.
- 这些发现凸显了糖尿病患者经常进行眼科查的重要性,糖尿病患者的功能受损.
- 旨在改善功能的干预措施可能会减轻DME的风险.
相关概念视频
Chronic Kidney Disease I: Introduction
552
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
552
Chronic Kidney Disease III: Interprofessional Care
331
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
331
Chronic Kidney Disease II: Clinical Manifestations
537
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
537
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
178
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
178
Chronic Kidney Disease IV: Nursing Management
308
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
308
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K


